HKPD · Cellyan Biotechnology Co Ltd
United States · RS rating 10 · As of 2026-10-14
| Price | 0.11 USD |
|---|---|
| 1-day change | +7.7% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 69 / 2 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 6 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +93.4% |
| Market cap (USD) | $14.6M |